The use of psychedelics for PTSD and drug-resistant depression has gained attention in recent months following the reclassification by Australia’s Therapeutic Goods Administration (TGA) from category nine to category eight.
The reclassification has meant that from July 1 this year, authorised psychiatrists can prescribe MDMA (or ecstasy) and psilocybin (or “magic mushrooms”) to treat some mental health conditions along with control measures.
